Literature DB >> 16236807

Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.

James C Rice1, Tao Peng, Jeff S Spence, Hui-Qun Wang, Randall M Goldblum, Blaise Corthésy, Bogdan J Nowicki.   

Abstract

P fimbriae are proteinaceous appendages on the surface of Escherichia coli bacteria that mediate adherence to uroepithelial cells. E. coli that express P fimbriae account for the majority of ascending urinary tract infections in women with normal urinary tracts. The hypothesis that P fimbriae on uropathic E. coli attach to renal epithelia and may regulate the immune response to establish infection was investigated. The polymeric Ig receptor (pIgR), produced by renal epithelia, transports IgA into the urinary space. Kidney pIgR and urine IgA levels were analyzed in a mouse model of ascending pyelonephritis, using E. coli with (P+) and without (P-) P fimbriae, to determine whether P(+) E. coli regulate epithelial pIgR expression and IgA transport into the urine. (P+) E. coli establish infection and persist to a greater amount than P(-) E. coli. P(+)-infected mice downregulate pIgR mRNA and protein levels compared with P(-)-infected or PBS controls at > or =48 h. The decrease in pIgR was associated with decreased urinary IgA levels in the P(+)-infected group at 48 h. pIgR mRNA and protein also decline in P(+) E. coli-infected LPS-hyporesponsive mice. These studies identify a novel virulence mechanism of E. coli that express P fimbriae. It is proposed that P fimbriae decrease pIgR expression in the kidney and consequently decrease IgA transport into the urinary space. This may explain, in part, how E. coli that bear P fimbriae exploit the immune system of human hosts to establish ascending pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236807     DOI: 10.1681/ASN.2005030243

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

Review 1.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

Review 2.  Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella.

Authors:  Glenn T Werneburg; David G Thanassi
Journal:  EcoSal Plus       Date:  2018-03

Review 3.  Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Authors:  Ariel R Brumbaugh; Harry L T Mobley
Journal:  Expert Rev Vaccines       Date:  2012-06       Impact factor: 5.217

4.  sRNA-Mediated Regulation of P-Fimbriae Phase Variation in Uropathogenic Escherichia coli.

Authors:  Surabhi Khandige; Tina Kronborg; Bernt Eric Uhlin; Jakob Møller-Jensen
Journal:  PLoS Pathog       Date:  2015-08-20       Impact factor: 6.823

5.  Whole genome sequence analysis of Australian avian pathogenic Escherichia coli that carry the class 1 integrase gene.

Authors:  Max L Cummins; Cameron J Reid; Piklu Roy Chowdhury; Rhys N Bushell; Nicolas Esbert; Kelly A Tivendale; Amir H Noormohammadi; Shaiful Islam; Marc S Marenda; Glenn F Browning; Philip F Markham; Steven P Djordjevic
Journal:  Microb Genom       Date:  2019-01-23

6.  Investigation of the Optimum Preparation of Peach Gum Polysaccharides and the In Vivo and In Vitro Therapeutic Effects on Acute Pyelonephritis.

Authors:  Feifei Zhang; Jie Bai; Yao Zheng; Shuai Liang; Lei Lei; Xin Deng; Weijun Li; Peng Liu; Guangzhong Yang; Yongshen Ren
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-12       Impact factor: 2.629

7.  Distribution of papG alleles among uropathogenic Escherichia coli from reproductive age women.

Authors:  Timothy Kudinha; Fanrong Kong
Journal:  J Biomed Sci       Date:  2022-09-07       Impact factor: 12.771

Review 8.  Cranberry juice-- a well-characterized folk-remedy against bacterial urinary tract infection.

Authors:  Rainer Nowack
Journal:  Wien Med Wochenschr       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.